Supplementary Materialscells-08-01258-s001 - New dimension in therapeutic targeting of BCL-2 family
Supplementary Materialscells-08-01258-s001 - New dimension in therapeutic targeting of BCL-2 family Skip to the content Close Menu Supplementary Materialscells-08-01258-s001. of WIP1 may boost sensitivity of BRCA1-proficient cancer cells to olaparib.